Article
Detection of pancreatic cancer using antibody microarray‐based serum protein profiling
1 Jun 2008
Abstract excerpt
The driving force behind oncoproteomics is to identify protein signatures that are associated with a particular malignancy. Here, we have used a recombinant scFv antibody microarray in an attempt to classify sera derived from pancreatic adenocarcinoma patients versus healthy subjects. Based on analysis of nonfractionated, directly labeled, whole human serum proteomes we have identified a protein signature based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
